Come up with a name for your new list and we'll add to it:
KineMed raised a round of funding on November 10, 2011. Investors include
Ledgemont Capital Group.
KineMed employs both pathway-based drug discovery and translational medicine-enabled drug development. KineMed's pathway-based discovery is based upon its ability to identify drugs with therapeutic ef…